Why the study?
Does α-Ketoglutarate improve cardiac insufficiency and alleviate cardiomyocyte damage in pressure overload-induced mice and AngII-treated cardiomyocytes?
Does α-Ketoglutarate improve cardiac insufficiency and alleviate cardiomyocyte damage in pressure overload-induced mice and AngII-treated cardiomyocytes?
α-Ketoglutarate alleviates cardiomyocyte damage and improves cardiac insufficiency by promoting mitophagy and inhibiting ferroptosis via the NAD+-SIRT1 signaling pathway.
No takes yet. Share an insight, caveat, or question.
AKG cardioprotection via SIRT1 remains hypothesis-generating in mice; leaves open translation to human cardiac insufficiency.
Yu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: